Clinical Trials · NCT05829460

Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

WithdrawnPhase 2Semaglutide (Prohibited)
Phase
Phase 2
Recruitment status
Withdrawn
Sponsor
Washington University School of Medicine
Enrollment
0
Start date
Mar 2025
Locations
See registry
Primary endpoint
Number of patients with endometrial hyperplasia free biopsy with uterine preservation
View Semaglutide compound reference